1. Home
  2. VTAK vs GNLN Comparison

VTAK vs GNLN Comparison

Compare VTAK & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • GNLN
  • Stock Information
  • Founded
  • VTAK 2002
  • GNLN 2005
  • Country
  • VTAK United States
  • GNLN United States
  • Employees
  • VTAK N/A
  • GNLN N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • GNLN Durable Goods
  • Sector
  • VTAK Health Care
  • GNLN Consumer Discretionary
  • Exchange
  • VTAK Nasdaq
  • GNLN Nasdaq
  • Market Cap
  • VTAK 1.4M
  • GNLN 1.3M
  • IPO Year
  • VTAK 2018
  • GNLN 2019
  • Fundamental
  • Price
  • VTAK $0.42
  • GNLN $1.80
  • Analyst Decision
  • VTAK
  • GNLN
  • Analyst Count
  • VTAK 0
  • GNLN 0
  • Target Price
  • VTAK N/A
  • GNLN N/A
  • AVG Volume (30 Days)
  • VTAK 532.2K
  • GNLN 3.3M
  • Earning Date
  • VTAK 11-13-2024
  • GNLN 11-15-2024
  • Dividend Yield
  • VTAK N/A
  • GNLN N/A
  • EPS Growth
  • VTAK N/A
  • GNLN N/A
  • EPS
  • VTAK N/A
  • GNLN N/A
  • Revenue
  • VTAK $399,000.00
  • GNLN $21,605,000.00
  • Revenue This Year
  • VTAK $637.10
  • GNLN $72.27
  • Revenue Next Year
  • VTAK $177.13
  • GNLN $93.46
  • P/E Ratio
  • VTAK N/A
  • GNLN N/A
  • Revenue Growth
  • VTAK 27.07
  • GNLN N/A
  • 52 Week Low
  • VTAK $0.31
  • GNLN $1.70
  • 52 Week High
  • VTAK $8.40
  • GNLN $21.80
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 41.01
  • GNLN 32.05
  • Support Level
  • VTAK $0.40
  • GNLN $1.82
  • Resistance Level
  • VTAK $0.62
  • GNLN $2.16
  • Average True Range (ATR)
  • VTAK 0.06
  • GNLN 0.31
  • MACD
  • VTAK -0.00
  • GNLN 0.01
  • Stochastic Oscillator
  • VTAK 9.59
  • GNLN 4.62

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a distributor of vaporization products and consumption accessories in the United States. It offers a selection of stock-keeping units including vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. The company markets and sells its products in both the business to business and business to consumer sectors of the marketplace. Its geographical segment includes the United States; Canada and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: